about
Metastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalitiesReactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer TherapyAdoptive cellular immunotherapy in metastatic renal cell carcinoma: a systematic review and meta-analysis.Effectiveness of immune therapy combined with chemotherapy on the immune function and recurrence rate of cervical cancer.Standard b-value versus low b-value diffusion-weighted MRI in renal cell carcinoma: a systematic review and meta-analysisIFNα2b augments immune responses of cisplatin+5-fluorouracil treated tongue squamous cell carcinoma patients--a preliminary study.ABCG2 is a potential prognostic marker of overall survival in patients with clear cell renal cell carcinoma.Low Expression of Mucin-4 Predicts Poor Prognosis in Patients With Clear-Cell Renal Cell Carcinoma.Proliferation inhibition and the underlying molecular mechanisms of microRNA-30d in renal carcinoma cells.Nivolumab in renal cell carcinoma: latest evidence and clinical potential.The urinary proteome and peptidome of renal cell carcinoma patients: a comparison of different techniques.The proteomic landscape of renal tumors.Hispidulin potentiates the antitumor effect of sunitinib against human renal cell carcinoma in laboratory models.Sphingosine kinase-1 activation causes acquired resistance against Sunitinib in renal cell carcinoma cells.Does patient-tailored immunotherapy pave the way for new renal cell carcinoma treatment perspectives?Hyper IgE Syndrome and Renal Cell Carcinoma.Spontaneous regression of biopsy proven primary renal cell carcinoma: A case study.Immune checkpoint inhibitors in renal cell carcinoma.Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma.Viroimmunotherapy for Colorectal Cancer: Clinical Studies.
P2860
Q26852437-044EA431-6063-46E6-B68D-01CACB0DC9ACQ33862425-F6C6A53F-87D5-4FA8-A96C-AD6D7BF22B28Q34717795-0F477116-6A77-4125-9258-AE0D9FDB22C8Q35048698-1F9BD8B3-7EAD-412F-9515-D5E9DBF84E7EQ35433649-87C8D44A-73FE-407E-8D07-60B88D9A836EQ36289634-8236A5E0-5F5D-4C45-BC84-6C5760D9019EQ36324336-E19BC863-1832-444C-8EA5-F92D75259910Q37206290-914715C3-08CD-4926-A3DC-51E2B16DCCE1Q37575126-43BE2458-F20D-4C69-A305-CB7734EA50F5Q37698611-7351D325-CCD5-4210-A97E-BD7AF2C8461BQ38217103-2BF77963-ED87-46BB-B2D6-5EF118D1CA44Q38803559-9E8315C8-C72A-4E24-8D9E-55F86A45864CQ38953038-8DD1BE67-D081-4BCA-961C-0FC939ED3FA3Q39105266-72314C9B-CD9A-473C-9718-86242449E688Q40054311-DF5E84AC-1DFD-4380-BCCC-3BCACF8FDF2DQ40174933-FAE4071A-7EB2-4E64-93EF-AF3F70E11ACFQ42409956-1532EBB4-F926-4393-999E-E4A17AB22399Q47592718-80D4D4E6-93A6-4E56-9A9F-DC8AF2F3D7DFQ53603499-F1ABD9B5-CBE0-483C-87FF-342B376F4611Q55085114-374D0CE0-2173-4EE4-AB43-FE92FDBFCDE8
P2860
description
im Jahr 2010 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2010
@uk
name
Immunotherapy for renal cell carcinoma
@en
Immunotherapy for renal cell carcinoma
@nl
type
label
Immunotherapy for renal cell carcinoma
@en
Immunotherapy for renal cell carcinoma
@nl
prefLabel
Immunotherapy for renal cell carcinoma
@en
Immunotherapy for renal cell carcinoma
@nl
P2860
P356
P1476
Immunotherapy for renal cell carcinoma
@en
P2093
Katsunori Tatsugami
Momoe Itsumi
P2860
P304
P356
10.1155/2010/284581
P407
P577
2010-01-01T00:00:00Z